Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-12-02

Clinical Trial Update: Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment [Phase 4]

View source ↗

Summary

A Phase 4 trial is evaluating Saccharomyces boulardii in combination with bismuth quadruple therapy as a rescue treatment for Helicobacter pylori infection; rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bismuth quadruple therapy
  • Saccharomyces boulardii (Saccharomyces boulardii)

Snippet

Sponsor: Yongquan Shi | Conditions: Gastritis, Dyspepsia | Phase 4 | Status: RECRUITING